Adherent cells from human immunodeficiency virus (HIV)-in-
Introduction
The human immunodeficiency virus (HIV) is the etiological agent of the acquired immunodeficiency syndrome (AIDS) (1, 2) . HIV selectively infects immunocompetent cells such as CD4 lymphocytes (3, 4) and macrophages (5, 6) . Although CD4' lymphocytes which is related to both the clinical outcome of the disease (9, 10) and the profound impairment of cell-mediated immunity (1 1-13). However, whether this immunodeficiency is due to the direct cytopathic effect ofHIV on CD4' cells or whether other indirect mechanisms are also involved in its pathogenesis is not yet clear. Indeed, although only a small number ofperipheral blood lymphocytes (PBL) of HIV-infected patients are expressing virus at any given time (14) , recent studies, using in situ hybridization and gene amplification showed that, at least 1/100 CD4' cells contains HIV-l DNA (15), indicating that the in vivo infection rate of CD4' cells is greater than initially thought.
Previous studies from our group and others have demonstrated that the proliferation and differentiation capacity of
T-cell progenitors (T-cell colony-forming cells [T-CFC]) are
reduced during HIV infection (16, 17), thus providing an additional mechanism which can lead to CD4 lymphopenia. Moreover, it has been shown that lymphocytes from HIV-infected subjects display a decreased expression of the a chain (Tac) of the interleukin-2 receptor (IL-2R)' upon mitogenic stimulation (18, 19) , indicating their impaired capacity for activation. Since CD4' lymphocytes have a key role on the regulation of the immune response, elaborating growth factors for both lymphocytes and myeloid cells (20) , their quantitative and qualitative abnormalities after HIV infection might be very important in the pathophysiology of the immunodeficiency. The qualitative defects of CD4' lymphocytes induced by HIV infection seems to be due to several causes. Indeed, it has been reported that noninfectious HIV can block antigenic activation of normal T cells through gpl2O (21, 22) . In addition, humoral factors produced by both lymphocytes (23) and adherent cells (24) of AIDS patients can inhibit normal T-cell activation. We have recently shown that adherent cells from AIDS patients produce spontaneously an activity which inhibits normal T-cell colony formation through decreased expression ofmembrane IL-2R (Tac molecule) and IL-2 production. Unpublished observations from our laboratory have demonstrated that this inhibitory activity can be detected in the supernatants of adherent cell cultures from 80% of HIV-infected subjects, irrespectively of the clinical stage.
Here we report on the partial biological and biochemical characterization of this inhibitory activity and we show that Tac-inhibitory activity is due to a 29-kD protein which is distinct from a-or y-interferon (IFN), prostaglandin E2 (PGE2), tumor necrosis factor a (TNFa), and the p24, gp120, and nef viral proteins.
Methods
Subjects. Heparinized peripheral blood was obtained from 60 HIVinfected patients at different stages of the disease as well as from HIV-seronegative patients suffering from Gram-positive (n = 3) and Gram-negative (n = 2) bacteremia, active toxoplasmosis (n = 3), active tuberculosis (n = 3), pulmonary aspergillosis (n = 1), and active cytomegalovirus (CMV) infection (n = 2). Confirmation of HIV infection was performed by enzyme-linked immunosorbent assay (ELISA) and Western blot analysis. Moreover, peripheral blood mononuclear cells (PBMC) were obtained from seronegative healthy blood donors (n = 15) and used for control experiments.
Preparation ofconditioned media. PBMC were isolated by FicollHypaque density gradient centrifugation. Adherent cells were separated by incubating 106 PBMC/ml in plastic Petri dishes in RPMI-1640 supplemented with 2 mM L-glutamine, and 1% (vol/vol) penicillinstreptomycin (all from Gibco Laboratories, Grand Island, NY) for 2 h in 5% CO2 in air at 37°C. Nonadherent cells (PBMCA-) were harvested by extensive (three times) washing of the dishes with Hank's balanced salt solution (HBSS). Adherent cells were resuspended in fresh serumfree culture medium supplemented with 10 ,g/ml leupeptine, I mM phenylmethylsulfonylfluoride (PMSF), and 10-' M pepstatin A (all from Sigma Chemical Co., St. Louis, MO). Cultures were incubated at 37°C in 5% CO2 in air for 48 h. Media conditioned by stimulated adherent cells were also obtained by preincubating the cells for 2 h in the presence of either phorbol myristate acetate (PMA; 10 ng/ml, Sigma Chemical Co.) or recombinant human granulocyte/macrophage colony-stimulating factor (GM-CSF; 10 U/ml, specific activity 108 CFU/mg, Genzyme Corp., Boston, MA), extensive washing, and further incubation in fresh medium as above. Supernatants from patients and normal subjects (LCM-A'p and LCM-A'n, respectively) were recovered, ultracentrifuged, filtered through 0.22-Am filters (Millipore Corp., Bedford, MA), and stored at -80°C until use.
In some experiments, media conditioned by T cell-enriched (E+) and T cell-depleted adherent (E-T3-A+) cells were also prepared as above. For this, unfractionated PBMC were subjected to rosetting with 2-amino-ethylisothiouronium bromide-treated sheep red blood cell and Ficoll-Hypaque density centrifugation. E+ cell fraction contained 93-95% CD3+ and < 4% OKM1+ cellsasdeterminedbyindirectimmunofluorescence using the OKT3 and OKM I MAbs (Ortho Pharmaceutical, Raritan, NJ). E-cells were further depleted of contaminating CD3+ cells by complement-mediated cytotoxicity using the OKT3 (Ortho Pharmaceutical) and Tl 1 (Coulter,AHialeah, FL) MAbs as described (25) and contained < 3% contaminating CD3+ cells. Plastic adherence of E-T3-cells was performed as above.
Determination ofprotein concentration. Protein quantification in each sample was determined according to the Shiffner and Weissmann technique (26) using BSA (Sigma Chemical Co.) solution as a standard. The minimum quantity of protein that could be measured by this method was -10 ng.
Expression ofthe Tac chain ofIL-2R. PBMC (106/ml) from normal healthy heterosexuals were incubated in RPMI-1640 supplemented with 10% FCS, 2 mM glutamine, and antibiotics. The cells were activated with phytohemagglutinin-M (PHA-M; 1% vol/vol, Difco Laboratories, Inc., Detroit, MI) in the presence of various concentrations of LCM-A'n or LCM-A'p for 48 h. Cells were washed with HBSS and tested for the expression ofthe Tac molecule by indirect immunofluorescence using the IOT14 monoclonal antibody (Immunotech, Luminy, France). At least 300 cells were counted under an epifluorescence microscope.
In some experiments, the inhibitory effect of LCM-A'p on the expression of the Tac molecule was studied after incubation with indomethacin (1 ug/ml, Sigma Chemical Co.) or increasing concentrations of anti-IFNa and anti-IFNy horse polyclonal IgG (25-100 U/ml, Boehringer Mannheim, Federal Republic ofGermany; 1 U ofIgG neutralizes I U of the corresponding IFN in a biological assay [27] ) or anti-TNFa (25-100 U/ml, Boehringer Mannheim; 1 U ofIgG neutralizes 1 U of TFNa on mouse L929-fibrosarcoma line [28] ) for 2 h at 4VC. In addition, the inhibitory effect of both recombinant a-IFN (5,000 U/ml Roche, Basel, Switzerland) and TNFa (2 U/ml, Genzyme Corp.) on the expression of Tac molecule was studied. Moreover, in some experiments TNFa was determined in LCM-A'p and LCM-A'n by a sensitive enzymato-immunoadsorbent assay (EIA) using a commercial kit (Biokine, T Cell Sciences, Inc., Cambridge, MA) according to the manufacturer's instructions. The specific inhibitory activity of each supernatant was expressed as the quantity ofprotein giving 50% of the maximal dinhibition (IDs13).
Detection ofvirus or/and viral proteins. All LCM-A'p were tested for the presence ofHIV-1 by measuring reverse transcriptase activity as reported (29) . Moreover NP-40-treated ultracentrifugated pellets of LCM-A+p and LCM-A'n were tested for p24 antigen by an EIA using a commercially available kit (Abbott Laboratories, Irving, TX). In addition, Amicon-concentrated LCM-A'p and LCM-A+n were electrophoresed according to the method of Laemmli (30) on a polyacrylamide gel using 7.5% acrylamide in the presence of 0.1% SDS (Sigma Chemical Co.). The samples were denaturated in 1% SDS and 1% glycerol (Sigma Chemical Co.), then electrotransfered, and blotted using a pool of MAbs against gpl 20 and p24 (Du Pont Co., Wilmington, DE) or purified human anti-HIV polyclonal IgG (kindly provided by Dr. T.
Jouault, Paris [311) as reported (32) . Detection ofviral proteins was also assayed by dot blot analysis of concentrated LCM-A'p or LCM-A+n using the above mentioned monoclonal and polyclonal antibodies. Finally, the Tac inhibitory activity was tested after incubating Amiconconcentrated LCM-A'p and LCM-A'n with either anti-gpl20 (5 jtg/ ml), anti-p24 (5 ,g/ml), and anti-nef (10 ,g/ml, kindly provided by Dr. P. M. Kieny, Transgene, Strasbourg, France) MAbs or increasing concentrations of purified human anti-HIV polyclonal IgG.
Cell infection. Adherent cells from HIV-seronegative normal blood donors were isolated as above and were incubated with 50 tissue culture ID5o units of HIV-1/106 cells in RPMI-1640 medium containing 2 ,gg/ml Polybrene (Sigma Chemical Co.) and sheep anti-human a-IFN serum (40 U/106 cells) for 1 h at 37°C in 5% CO2 in air. In control experiments, inactivated virus (heated for 1 h at 56°C) was incubated with adherent cells. Subsequently, the cells were washed three times with complete culture medium, resuspended in fresh culture medium at 106 cells/ml, and cultured in the presence of PMA (10 ng/ml) and 5 U/ml GM-CSF. Every third day the cells were counted and the supernatants were tested for p24 antigen and reverse transcriptase activity as reported (1) . The remaining cells were recultured in fresh culture medium supplemented with PMA and GM-CSF. Cultures were performed at 37°C in 5% CO2 in air.
An aliquot of culture supernatants as well as supernatants from productively HIV-l-infected U937 cells maintained in long-term culture (kindly provided to us by Dr. J. C. Gluckman, Hopital PitieSalp&riere, Paris) were ultracentrifugated, and the supernatants were tested for their capacity to inhibit the expression of Tac molecule. These ultracentrifugated supernatants did not contain reverse transcriptase activity, p24 antigen, or secreted p24 and gpl20 proteins as assessed by both p24 capture EIA and dot blot analysis using purified human polyclonal anti-HIV IgG.
IL-2 dosage. IL-2 was determined in media conditioned by PHAactivated normal PBMC in the presence or the absence of inhibitory factor by a oolorimetric method using the IL-2-dependent CTLL-2 cell line according to Mosman (33) technique as modified by Tada (34) . The results are expressed as Biological Response Modifiers Program (BRMP) units per milliliter.
Partial biochemical characterization ofthe inhibitory activity. Amicon (YM5 membrane)-concentrated supernatants (XI 00) were salted out with a G25 gel filtration column (Pharmacia, Uppsala, Sweden; 15 cm 1.5 cm2), at room temperature. The column was equilibrated with 20 mM Tris-Cl, 1 M NaCl, 4 M urea (Merck, Darmstadt, FRG), I mM EDTA (Merck), I mM EGTA, pH 7.4 buffer supplemented with the previously mentioned protease inhibitors. The proteins contained in the void volume were Amicon concentrated, and 300 Ml ofthe solution was injected on a fast protein liquid chromatography S12 gel filtration column (Pharmacia) equilibrated with the same buffer in the presence of protease inhibitors. The column was run at 20'C with a 0.5 ml/min flow rate. The calibration of the S12 column was performed with the Pharmacia calibration kit. The various fractions were Amicon (YM5)-concentrated, salted out on a G25 column equilibrated with 20 mM Tris-Cl, pH 7.4, supplemented with protease inhibitors. All fractions were Millipore filtered and tested for biologic activity. The void volume of the biologically active fractions was run on an anion exchange column (Mono-Q, Pharmacia) equilibrated with the same buffer. The retained proteins were eluted with a linear NdCl gradient (0-3 M NaCl) in the same buffer. The biologically active peaks were analysed by SDS-PAGE as described above.
Elution ofthe proteins from the gels. Fig. 1 . This pattern of dose-response curves was very similar in the 60 cases studied. LCM-A+ from AIDSrelated complex (ARC) and AIDS patients displayed a lower ID50 than from asymptomatic and lymphadenopathy syndrome (LAS) patients (Table III) but these differences were not statistically significant. Supernatants displaying an ID50 < 0. 4 Mug/106 cells were considered to contain Tac-inhibitory activity.
Using these criteria, this activity could be detected in 55% of asymptomatic seropositive patients, 70% LAS, 71% ARC, and 100% AIDS patients. ( Table III) Production of Tac-inhibitory activity. Kinetic studies revealed that the production of Tac-inhibitory activity became detectable after a 12-h cell incubation, reaching a plateau at 48 h (Fig. 3) . However, when the LCM-A'p were prepared in the absence of protease inhibitors, the specific activity declined at 72 h.
Stimulation of adherent cells with rGM-CSF or PMA enhanced both total protein production and the secretion ofTacinhibitory activity in all but one case (case 3, Table IV ). It should be noted that in both PMA-and recombinant GM-CSF-induced and ultracentrifugated LCM-A'p neither reverse transcriptase activity nor p24 and gp 120 viral proteins could be detected by dot blot using specific MAbs (not shown). Moreover, no p24 antigen could be detected in these supernatants using a capture EIA.
Tac-inhibitory activity is not infectious HIV or/and HIV gag-, env-and nef-encodedproteins. All LCM-A'p were tested for reverse transcriptase activity and for their capacity to infect the CEM-A310 leukemic T activity or infection of the permissive cell line could be detected, as previously reported (24) . In some experiments, LCM-A+p were also used to infect PHA blasts. Again, no virus replication could be obtained during the 28-d culture period as assessed by both reverse transcriptase activity and p24 antigen in the culture supernatants. No LCM-A'p were positive for p24 antigen when tested in a capture EIA. To more directly exclude the presence of viral proteins, concentrated LCM-A+p were also tested for the presence ofgag and env proteins by dot as well as by Western blot analysis using either specific monoclonal antibodies or purified human polyclonal anti-HIV IgG. In several experiments performed using different LCM-A'p, no p24 or gpl 20 proteins could be revealed. In addition, the Tac-inhibitory activity could not be abrogated by either antigpl20, anti-p24, and anti-nef MAbs, or purified human anti-HIV polyclonal IgG. Tac-inhibitory activity is distinctfrom PGE2, a-and y-IFN, and TNFa. We subsequently studied whether media conditioned by HIV-infected subjects' adherent cells contain PGE2, a-or y-IFN, or TNFa, which display a known inhibiting effect on cell proliferation. Purified polyclonal horse IgG which has been shown to neutralize a-IFN, y-IFN, and TFNa in corresponding biological assays (27, 28) could not abbrogate Tac-inhibitory activity of all conditioned media tested even at high antibody concentrations. Moreover, no TNFa could be detected by EIA in 10 out of 10 supernatants tested. In addition, when normal PBMC were stimulated in the presence ofrecombinant a-IFN (5,000 U/ml) and TNFa (2 U/ml), no inhibition of Tac expression could be detected (not shown). Finally, a concentration as high as 1 ,ug/ml of indomethacin could not abrogate the inhibitory activity of LCM-A'p (not shown).
Partial biochemicalcharacterization ofTac-inhibitoryactivity. We have previously shown that Tac-inhibitory activity could be abolished by trypsin and chymotrypsin-treatment or heating ofthe conditioned media at 560C for 1 h (24). In order to more precisely characterize the molecule responsible for this activity, LCM-A'p were salted out by chromatography on G25 column and proteins were gel filtrated on S12 fast protein liquid chromatography column in the presence of4 M Urea. Fig. 4 A shows the elution profile revealing that the biologic activity was co-eluted at 23 kD. The value of IDe of the 23-kD active fraction was decreased 425-fold in comparison to the crude LCMA+p when tested in the same PBMC.
The 23-kD fraction was, subsequently, salted out on a G25 column and subjected to an anion exchange (Mono-Q) column. The biologic activity was detected in the non-retained fraction (Fig. 4 B) which represents 5% of the total quantity of protein applied to the column. Again, ID50 value of the nonretained fraction was threefold lower than that of the 23-kD fraction obtained by gel filtration, tested on the same PBMC. Thus, after these two steps of chromatography the calculated degree of purification in terms of TDs5, was 1,200-fold (Fig. 5) .
In some experiments, both crude conditioned medium and the collected fractions from S12 and Mono-Q chromatography were tested using the same target cells. In all cases, the same pattern of dose-response curve of the biologic activity was observed without modification of the maximal inhibitory effect.
Conversely, only a progressive decrease ofthe ID5 ofthe active fractions obtained at each purification step was observed, suggesting that the same biologic effect was detected throughout the whole purification procedure.
SDS-PAGE and elution ofthe active molecule. Gel electrophoresis of the active fraction obtained after Mono-Q chromatography revealed three groups of proteins at 44, 35, and 29 kD. After elution of the gel, the biologic activity was associated with the 29-kD protein (Fig. 6) . No cytotoxicity was detected in the eluted and dialyzed fractions. The biologic activity could be recovered after denaturation in the presence of 1% SDS.
Discussion
The results presented here indicate that adherent but not T cells from HTV-infected subjects produce spontaneously a 29- kD protein, capable of inhibiting the expression of Tac molecule on normal activated T cells and the production ofIL-2 by these cells. In addition, this inhibitory factor is able to inhibit mitogenic-and alloantigen-induced proliferation of normal T cells (manuscript in preparation). This lack of detection ofthe Tac molecule was shown not to be due to steric hindrance but to active suppression of its expression. The cellular origin of p29 molecule was further confirmed by the observation that complement-mediated lysis with My9 MAb completely abrogated its production. Moreover, recombinant GM-CSF and PMA, which can stimulate macrophages/monocytes increases both the total protein secretion and the production ofTac-inhibitory activity (Table IV) . Taken together these findings strongly suggest that p29 is actively secreted by adherent cells and that its release is a time-dependent phenomenon.
Tac-inhibitory factor could not be detected in media conditioned by normal unstimulated or activated adherent cells nor by adherent cells from patients infected with Gram-positive or Gram-negative bacteria, and intracytoplasmic microbial agents (Table III) . Only a very low production of Tac-inhibitory activity which, according to our criteria could not be considered significant (IDjo > 0.5 ,ug/106 cells), could be detected in media conditioned by adherent cells from patients with active CMV infection. However, no anti-CMV IgM antibodies, demonstrating a recent CMV primary infection, could be detected in the HIV-infected subjects included in the present study. On the contrary, a production ofTac-inhibitory activity was observed in culture supernatants from in vitro HIV-infected normal adherent and U937 leukemic cells indicating that the production of the inhibitor is clearly related to HIV infection. Thus, these observations seem to indicate that the secretion of Tac-inhibitory factor is specific to HIV infection. However, we cannot completely exclude that other viral infec- tions could also induce the production ofTac inhibitory activity, thus explaining the higher proportion ofpatients with more advanced clinical stages of HIV infection producing this activity. The determination of the ID50 of different LCM-A'p always revealed a plateau ofthe biologic activity. This pattern of activity seems to indicate that the 29-kD inhibitory protein could inhibit Tac expression on only a subset of normal T lymphocytes. Indeed, p29 inhibits Tac expression on CD8' (up to 60%) but not on CD4' (up to 15%) cells as determined by two color fluorescence analysis (manuscript in preparation). Alternatively, this molecule could inhibit Tac expression through an indirect mechanism, i.e., inhibiting the production of a factor necessary for cell activation.
As monocytes/macrophages can be infected with HIV (5, 6) and virus replication can be enhanced in the presence ofrecombinant GM-CSF or cell activation (35) , it was critical to define whether Tac-inhibitory activity could be due to released viral particles. This question was important since patients' adherent cells expressed p24 and gpl20 viral proteins and contained integrated viral sequences (not shown) indicating their HIV infection. Several arguments are against this possibility: (a) no reverse transcriptase activity or HIV p24 antigen could be detected in conditioned media; (b) conditioned media could not infect the HIV-permissive CEM-A310 leukemic cell line as well as normal PHA blasts as already reported (24); (c) no HIV gag and env proteins could be revealed by both Western and dot blot assays using either MAbs or purified human polyclonal anti-HIV IgG (Fig. 4) . The absence of detection of viral proteins does not seem to be due to technical reasons, since dot blot assays were performed using a high quantity (3 ,g) ofprotein which saturated the experimental system; (d) finally, Tacinhibitory activity could not be abolished by both monoclonal antibodies against both the p24, gp 120, and nef viral proteins as well as purified human polyclonal anti-HIV IgG. Taken together these observations seem to indicate that Tac-inhibitory factor is of cellular origin, although the possibility of its being a product ofa viral regulatory gene cannot be completely ruled out.
Several cellular factors display inhibitory effects on the proliferation of normal cells (36) (37) (38) . Our findings indicate that Tac inhibitor is not PGE2 since indomethacin cannot abrogate the biologic effect of LCM-A'p. Moreover, this inhibitor is distinct from a-and -y-IFN and TNFa, since polyclonal neutralizing purified horse IgG against these molecules could not inhibit the biologic activity. In addition, LCM-A'p did not contain detectable amounts of TNFa and recombinant TNFa could not enhance Tac expression on normal activated T cells in the presence of the Tac-inhibitory activity as it does in the absence ofthe inhibitor as already reported (35); finally, recombinant a-IFN could not inhibit Tac expression on normal activated T cells.
Preliminary biochemical characterization of this activity suggested a protease-sensitive molecule (24) . In the present study we confirmed this observation since the detection ofTacinhibitory activity was decreased at 72 h when LCM-A'p were prepared in the absence of protease inhibitors whereas in the presence of protease inhibitors, a plateau was obtained at 48 h (Fig. 2) . Gel filtration revealed that the biologically active molecule was co-eluted with an apparent molecular mass of 23 kD which could not be retained by an anion exchange column suggesting its cationic nature. Our findings concerning the determination of the IDso indicate that with these preliminary purification steps, Tac-inhibitory factor could be purified about 1,200-fold. When this non-retained fraction was subjected to SDS-PAGE, three bands of about 44, 35, and 29 kD were revealed. Protein elution from the gels and study of their capacity to inhibit Tac expression demonstrated that the biologic activity was associated only with the 29-kD protein.
Previous studies have already shown that both unstimulated and mitogen-activated peripheral blood lymphocytes from AIDS patients can inhibit the proliferation of normal lymphocytes (23) . Moreover, T-cell hybridomas from AIDS patients also produce constitutively inhibitory activity(ies) for normal cell proliferation (39) . Although biochemical studies have not been performed in these reports, the different cell origin of Tac-inhibitory factor suggests that these activities are distinct. In addition, it has been recently reported that AIDS patients' bone marrow cells produce a molecule of 84 kD which inhibits the proliferation of normal GM-CFU (40), which it should be different from p29 inhibitory factor on the basis of their molecular mass.
In conclusion, our findings taken together with previous studies strongly suggest that defective T cell responses in vitro upon mitogenic or antigenic stimulation during HIV infection might be the result of several pathophysiologic mechanisms such as (a) impaired proliferation and differentiation of T-cell precursors into mature CD4' cells due to their infection with the virus (41), (b) HIV-induced cytopathic effect on infected and noninfected CD4' lymphocytes (12) , (c) direct cell inhibitory effect of the envelope gpl2O viral protein (22) , and (d) production ofT-cell activation and proliferation inhibitory factor(s) by infected macrophages-monocytes and T cells (23, 24) .
